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Abstract
Background: In 2011 a consensus statement from the British Association of Paediatric Urologists recommended lowering the age
at orchidopexy to under 1 year. There are concerns that a younger age at operation may increase postoperative testicular atrophy.
The ORCHESTRA study aimed to establish the current age at orchidopexy in a multicentre, international audit and to see whether
testicular atrophy was affected by age at operation.
Methods: The study was undertaken over a 3-month period in 28 centres in boys undergoing orchidopexy for unilateral, palpable un-
descended testes. Data collection was done using a standardized, predetermined protocol. The primary outcome was postoperative
testicular atrophy. Secondary outcomes were wound infections, reoperations, and unplanned hospital stays related to anaesthetic
events.
Results: A total of 417 patients were included, of whom only 48 (11.5 per cent) underwent orchidopexy before 1 year of age.
There was no difference in anaesthetic complications in boys aged less than 1 year versus older patients: 0 of 48 (0 per cent) versus
6 of 369 (1.6 per cent) (P¼ 0.999). Complete follow-up was available for 331 patients (79.4 per cent). There was no difference in atrophy
rate between those aged less than 1 year and older boys: 1 of 37 (3 per cent) versus 9 of 294 (3.1 per cent) (P¼ 0.999). Reoperation rates
were 0 of 37 (0 per cent) and 7 of 294 (2.4 per cent) respectively (P¼ 1.000). There were more wound infections in boys under 1 year of
age: 4 of 37 (11 per cent) versus 7 of 294 (2.4 per cent) (P¼ 0.025).
Conclusion: Only 11.5 per cent of boys underwent surgery before the age of 1 year. There was no increased risk of postoperative
testicular atrophy with early surgery, although there was a higher rate of wound infection. Further study is required to demonstrate
that early orchidopexy is not inferior to orchidopexy undertaken in boys aged over 1 year.
Introduction
In September 2011 the British Association of Paediatric Urologists
(BAPU) published a consensus statement recommending that
orchidopexy should be performed in boys from as young as
3 months of age, although surgery at 6–12 months was consid-
ered acceptable1. This was based on evidence that operating at
an earlier age may improve fertility and reduce the long-term
risk of testicular malignancy2–5. It also assumed that unde-
scended testes that have not descended spontaneously by
3 months of age are unlikely to do so by 1 year6. Since then, other
professional bodies7,8 have issued similar guidance supporting
early orchidopexy, and a recent meta-analysis9 concluded that
the ideal age for orchidopexy was 6–12 months.
There is, however, a lack of evidence to ensure that changes in
practice do not have unforeseen negative consequences. Surgery
for undescended testes may result in testicular atrophy, and it is
not known whether operating at a younger age may increase the
risk of postoperative testicular atrophy10. There is also height-
ened awareness of the possible detrimental effects of general an-
aesthesia on the developing brain, resulting in a US Food and
Drug Administration safety communication about use of general
anaesthetics in children aged less than 3 years11.
The ORCHESTRA (ORCHidopexy: does Earlier Surgery affect
Testicular Atrophy?) study was designed as a multicentre, inter-
national audit of current practice of orchidopexy in relation to
BAPU guidance, and established current rates of testicular atro-
phy after orchidopexy.
Methods
The study was a multicentre, international trainee-led prospec-
tive audit of practice led by the UK-based Paediatric Surgical
Trainees Research Network (PSTRN). Data were recorded from an
inception cohort of boys undergoing orchidopexy for unilateral,
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palpable undescended testis. Data were collected from each cen-
tre over 3 months and outcomes recorded for boys with at least
6 months of follow-up. Results are reported in accordance with
the STROBE guidelines12. No preregistration exists for the study
reported in this article.
Centre eligibility
Any hospital that provided elective general paediatric surgery in
the UK was eligible to enter patients. International centres were
contacted through trainee links to these countries. In the UK,
trainees ensured that there was consultant oversight and agree-
ment in departments to participate. Each centre registered the
study locally as a clinical audit. International centres followed lo-
cal ethical approval procedures. Data collection was completed
by surgical trainees.
Patient eligibility
All boys aged less than 16 years in whom orchidopexy was per-
formed for unilateral, palpable undescended testis were eligible
for inclusion. The testis was considered palpable either during
preoperative clinical examination or during examination under
general anaesthesia. Patients who required laparoscopy to deter-
mine testicular position were excluded. Boys who had a known
endocrine or genetic condition that could affect testicular growth,
and those who underwent orchidopexy following ipsilateral in-
guinal hernia repair were also excluded.
Study outcomes
The audit standard was defined as the proportion of boys who re-
ceived orchidopexy before 12 months of age, and was set at
100 per cent. The age at referral was also registered to determine
whether delays in timing of orchidopexy were attributable to late
referral.
The primary postoperative outcome was the rate of testicular
atrophy at least 6 months after orchidopexy. The audit standard
was set at less than 5 per cent testicular atrophy based on a re-
cently published large retrospective case series10. Testicular atro-
phy was measured in comparison with the contralateral,
normally descended testis. At the time of orchidopexy, the sur-
geon was asked to note the volume of the testis as a proportion of
the contralateral testis using one of the following categories: less
than 25 per cent; 25 per cent or more but less than 50 per cent;
50 per cent or more but less than 75 per cent; 75 per cent or more
but less than 100 per cent; 100 per cent; or more than 100 per
cent. At follow-up, the clinician was again asked to note the tes-
ticular size compared with the contralateral testis. Testicular at-
rophy was defined as a greater than 50 per cent decrease in size
to allow for the fact that this was a pragmatic and subjective
measurement, and that small differences may be due to inter-
rater variability and differences in time interval between assess-
ments.
Secondary outcomes included: rate of reoperation/testicular
ascent, defined by a testis that was palpable at follow-up but no
longer in a scrotal position and deemed to require further sur-
gery, where the audit standard was set at less than 2 per cent13; a
surgical-site infection rate less than 2 per cent where infection
was defined by purulent drainage from the incision or at least
two of: pain or tenderness, localized swelling, redness, heat, fever
diagnosed by the clinician as representing a surgical-site infec-
tion, or organisms and pus cells from an aspirate or wound swab
(data were collected on whether patients were given antibiotic
treatment for presumed wound infection)14; and an unplanned
overnight stay as a result of an adverse anaesthetic event, where
the standard was also set at less than 2 per cent15.
Data collection
Data were collected for each eligible patient using a standardized
online electronic pro forma. Patients were identified on a weekly
basis from planned elective lists. Preoperative data such as age at
referral and operative data were registered by or with the operat-
ing surgeon at the end of the list. Follow-up information was
collected at the outpatient clinic at least 6 months after orchido-
pexy.
Anonymized patient data were entered into an online
database via a secure webpage. Each data collector was granted
password access, and a study number was allocated once an indi-
vidual patient data collection form had been completed. Trainees
entering the data then kept a secure record on the hard drive of a
hospital network computer linking the study number to a hospi-
tal number used for follow-up. The website generated automatic
e-mail reminders when follow-up was planned.
Study size design and bias
A local audit was performed at the lead centre (Oxford Children’s
Hospital), which performs about 100 orchidopexies per year, to
inform the study design. Of these, about 20 per cent are for intra-
abdominal or bilateral undescended testes. A 3-month data
collection period was chosen as a balance between achieving rea-
sonable numbers from each centre (estimated at 20 per paediat-
ric surgical centre) and a short enough time frame for
enthusiasm for the study to be sustained. The plan was to recruit
10 paediatric surgical centres and recruit 200 patients over
3 months. In addition, recognizing that more than half of all
orchidopexies in the UK are performed in district general hospi-
tals16, often by adult general surgeons or urologists with a spe-
cialist interest in general paediatric surgery, the study aimed to
recruit 20 district hospitals through the national research collab-
orative of adult surgical trainees to obtain a further 200 patients,
based on data from a moderately sized hospital that reported
about 35 orchidopexies per year17.
Statistical analysis
Planned statistical analysis included comparing postoperative
outcomes between patients operated at less than 1 year of age
compared with older patients, using Fisher’s exact test or v2 test
for categorical data. Only patients who had completed at least
6 months of follow-up were included in the outcome analysis.
Results
Some 417 patients were included from 28 centres (13 paediatric
surgical centres in the UK, 11 general hospitals in the UK, 4 inter-
national paediatric centres in Argentina, Austria, Finland, and
Lithuania). A further five district general hospitals that registered
to take part in the audit did not perform any orchidopexies dur-
ing the data collection period.
Results were available on age at referral for 356 boys (85.4 per
cent). The median age at referral was 1 year 8 months (range
1 day to 15 years 1 month). Of the 356 boys, 117 (32.9 per cent)
were referred before 1 year of age. Of the 417 boys, 92 (22.1 per
cent) had previous documentation of intrascrotal testes by a
health professional before diagnosis of an undescended testis
and referral.
The median age at surgery was 2 years 6 months (range
3 months to 15 years 4 months), although there was a bimodal
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distribution with a peak between 1 and 2 years of age, and a fur-
ther smaller peak at around 10 years (Fig. 1). The median age at
surgery for boys who had ascending testes was 6 years 1 month;
when these boys were excluded, the median age at surgery for
those with congenital undescended testis was 2 years.
Only 48 of 417 boys (11.5 per cent) underwent orchidopexy be-
fore 1 year of age. Of the 28 centres, 17 treated boys who were
aged less than 12 months at the time of orchidopexy. All of the
overseas centres performed orchidopexies in boys aged less than
12 months, as did 11 of the 13 UK paediatric surgical centres, but
only 2 of the 11 general hospitals. When those with ascending
testes were excluded, the proportion of boys who received sur-
gery before 1 year of age was 14.4 per cent.
Surgical details
Some 356 patients (85.4 per cent) had surgery in the UK, 58 (16.3
per cent) in general hospitals and 298 (83.7 per cent) in paediatric
surgical centres.
In UK specialist centres, the primary operator was a consul-
tant in 30.2 per cent of operations whereas in non-specialist
centres the primary operator was a consultant 84 per cent of the
time. In specialist centres in the UK and overseas, unsupervised
trainees performed 11.4 and 16 per cent of procedures respec-
tively (Table 1).
Twenty-five boys (6.0 per cent) had an undescended testis that
was impalpable until they were anaesthetized; 60.0 per cent of
undescended testes (250 of 417) were right-sided. Some 376 boys
(90.2 per cent) underwent surgery via a groin incision and a sepa-
rate scrotal incision, whereas 41 (9.8 per cent) had a single scrotal
incision.
As the study was limited to orchidopexies for testes that were
palpable under general anaesthesia, 160 (38.4 per cent) were
found within the inguinal canal, 231 (55.4 per cent) in the superfi-
cial inguinal pouch below the external ring of the inguinal canal,
and 26 (6.3 per cent) had an ectopic location (3 perineal, 8 lateral
to the scrotum, 5 lateral to the external ring, and 10 described as
ectopic but without a precise location) (Table 2).
At the time of orchidopexy, 323 out of 417 (77.5 per cent) of un-
descended testes were recorded to be at least 75 per cent of the
volume of the contralateral testis. Only 9 per cent were less than
half the volume of the contralateral testis. In 86 patients (20.6 per
cent) the undescended testis was noted to have a dissociated vas.
Testicular atrophy
Follow-up at 6 months after orchidopexy was available for 331
patients (79.4 per cent). Of these, 10 (3.0 per cent) had an atrophic
testis (reduction in size compared with time of operation of more
than 50 per cent). There was no significant difference in testicular
atrophy between those operated before 12 months and those
who had surgery after 12 months of age: 1 of 37 (3 per cent) versus
9 of 294 (3.1 per cent) (P¼ 1.000) (Table 3). Among operations per-
formed by a trainee without consultant supervision, only one pa-
tient (2 per cent) developed testicular atrophy.
Testicular re-ascent
Seven testes (2.1 per cent) were noted to have ascended after sur-
gery. None of the patients with testicular re-ascent underwent
orchidopexy before 12 months of age. A further 12 patients (3.6
per cent) were booked for further follow-up because their testes
were high in the scrotum and there was concern that they may
need further surgery. None of the testicular re-ascents were in
patients operated via a single trans-scrotal incision.
Anaesthetic complications
There were six unplanned overnight admissions (1.4 per cent). In
two patients, apnoeic events occurred in recovery, one patient
was slow to wake, two required additional pain relief (1 had un-
dergone circumcision under the same general anaesthetic), and
one patient did not pass urine for several hours and also had
issues with pain management. None of infants under 12 months



































Fig. 1 Age at orchidopexy
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Surgical-site infections
There were more wound infections in younger boys: 4 of 37 (11
per cent) operated under 12 months of age versus 7 of 294 older
boys (2.4 per cent); this was statistically significant (p¼ 0.025).
Discussion
This study did not show an increase in testicular atrophy among
boys who had surgery at less than 12 months of age, suggesting
that current guidance is not associated with worse early postop-
erative outcomes. The 3.0 per cent rate of testicular atrophy is
less than the preset audit standard of 5 per cent, and similar to
that reported in recent observational studies10,18,19, which ranged
from 2.6 to 5.0 per cent.
The rate of testicular re-ascent was similar in boys operated at
less than 12 months and those operated after 12 months. There
was a 2.1 per cent rate of reoperation during follow-up, in line with
the audit standard of 2 per cent. Although there were no cases of
testicular re-ascent in boys operated before 12 months of age, this
result was not statistically significant reflecting the small numbers
in this group. There may be advantages to operating at a younger
age because the testis is moved a shorter distance in absolute
terms. However, a further 12 patients (3.6 per cent) remained under
review owing to concerns that the testis was lying high in the scro-
tum and redo orchidopexy might be needed. A weakness of the
study was that longer follow-up was not obtained to check that the
redo surgery rate was not higher than that reported.
In orchidopexies performed via a single trans-scrotal incision,
reported rates of testicular re-ascent vary from 0 to 4.5 per
cent19,20. There were no testicular re-ascents in boys who under-
went orchidopexy via a single trans-scrotal incision in the pre-
sent study, supporting its use in selected patients.
Anaesthetic complication rates were also similar in both
groups, and there was a low overall rate of unplanned postopera-
tive admissions of 1.4 per cent, compared with the audit standard
of less than 2 per cent. There were no adverse anaesthetic events
recorded in boys operated under 1 year of age. However, the
APRICOT study21, which included over 30 000 children who had a
general anaesthetic, found that there was a 12 per cent decreased
risk of anaesthetic complication for each additional year of age. A
weakness of the present study was that no data were collected
on intraoperative anaesthetic events.
In the present study, there was a significantly increased risk of
surgical-site infection requiring antibiotics in boys under
12 months of age. In this age group, the wounds are more likely
to be exposed to urine and faecal contamination from wearing
nappies. It may be that the younger boys would benefit from an
occlusive dressing or wound glue application22.
There are several limitations to this study. It was hoped to in-
clude more non-specialist centres in the UK through the adult
surgical trainee research networks, but only 16 centres were
recruited. A much smaller number of orchidopexies was under-
taken in each district hospital than predicted and several regis-
tered hospitals performed no orchidopexies during the study
interval. The majority of orchidopexies were done in specialist
centres and, although they showed equivalent outcomes in dif-
ferent age groups, it is not clear whether this would be the case
outside specialist centres. Only four boys under the age of 1 year
had surgery in non-specialist centres. In the UK this has implica-
tions for the design of treatment pathways for undescended
testes. Until recently, most orchidopexies were performed in
non-specialist centres; however, there has been a trend towards
more children receiving surgery in specialist centres and trying to
achieve a younger age at orchidopexy may further accelerate
this16,23,24.
Despite most orchidopexies being performed in specialist
centres, only 11.5 per cent of procedures in this study were un-
dertaken before 12 months of age, and this meant the compari-
sons of outcomes involved very unequal numbers of patients.
The reasons for older age at orchidopexy appeared to be multi-
factorial, including delayed referral, waiting times, and ascending
testes. In this cohort, 22.1 per cent of boys had an undescended
testis that had been documented previously as intrascrotal by a
health professional. This is not dissimilar to the rate in a multi-
centre study25 in Germany, which found that 27 per cent of
orchidopexies were performed for ascending testis. In the UK,
baby checks are carried out routinely at 6–8 weeks of age by pri-
mary care physicians. The prevalence of cryptorchidism has been
reported to fluctuate during the first year of life, starting at
5.9 per cent of newborns and dipping to 2.7 per cent at 3 months,
before unexpectedly rising again to 6.7 per cent at 1 year of age26.
Baby checks may well take place when more testes are palpable
in the scrotum, but a proportion of these ascend over time. The
latest edition of Health for All Children27, which describes best prac-
tice for health screening in primary care, emphasizes urgent re-
ferral for bilateral undescended testes found at the 6-week check,
but makes no recommendation for management of unilateral
undescended testes. The recent commissioning guide for paediat-
ric orchidopexy28 published by the Royal College of Surgeons of
England recommends referral at 6 months of age for unde-
scended testes.




Superficial inguinal pouch 231 (55.4)
Ectopic 26 (6.3)
Values in parentheses are percentages.
Table 3 Early postoperative complications after orchidopexy
according to age at operation
Age at operation
 12 months > 12 months P*
(n¼37) (n¼294)
Testicular atrophy 1 (3) 9 (3.1) 1.000
Testicular re-ascent (redo
orchidopexy)
0 (0) 7 (2.4) 1.000
Surgical-site infections 4 (11) 7 (2.4) 0.025
Values in parentheses are percentages. *Fisher’s exact test.













Consultant 90 (30.2) 49 (84) 30 (49)
Trainee, supervised 174 (58.4) 9 (16) 21 (34)
Trainee, unsupervised 34 (11.4) 0 (0) 10 (16)
Values in parentheses are percentages.
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Only 79.4 per cent of the patients in this study had follow-up
documented at 6 months following surgery. As the study was reg-
istered as a prospective audit of practice, direct contact with
study participants outside of the usual standard of care was not
permitted. A study29 that looked at factors associated with non-
attendance at follow-up reported a similar 80 per cent atten-
dance rate for orchidopexy follow-up visits in the Canadian
healthcare system. The loss to follow-up of some 20 per cent of
patients means that there was systematic bias in the outcome
reporting of postoperative testicular atrophy. As the baseline
demographics of patients with or without follow-up were similar
(Table S1), it seems likely that that parents would be more in-
clined to attend follow-up if they had ongoing concerns, so un-
derestimation of the rate of atrophy seems unlikely.
Testicular volume was assessed clinically by the surgical team
responsible for the patient, leading to observer bias and inter-
rater variability. The study protocol minimized these risks by
requesting that testicular volume was compared with that of the
contralateral testis, and that the volume had to decrease by two
groups (over 50 per cent difference) in the classification system to
count as testicular atrophy. There is a lack of consensus regard-
ing what constitutes testicular atrophy. Ein and colleagues de-
fined testicular atrophy as a loss of volume of more than one-
third compared with the contralateral testis10, whereas Carson
et al.18deemed that more than 50 per cent loss of volume counted
as testicular atrophy. Both sets of data were collected retrospec-
tively from chart reviews relying on physician descriptions of the
testis and it is unclear how testicular volume was assessed or
consistently documented. The ORCHESTRA study had clear defi-
nitions of how to assess and classify testicular size. This, along
with contemporary data collection, should have improved the ro-
bustness of the data.
The pragmatic design of the study is reflective of standard
clinical practice and so the results should be generalizable. There
was no restriction on the operating grade of the surgeon or the
surgical approach. The results did not show worse outcomes in
patients who had been operated on by trainees, and support
unsupervised trainee operating when trainers consider their
trainees competent to perform an orchidopexy.
Robust evidence is still needed to influence clinicians to refer
boys at an earlier age for consideration of orchidopexy, and to
satisfy surgeons that there is no increased risk of early postopera-
tive complications. The present study did not show an increased
risk of postoperative testicular atrophy in boys who had surgery
at less than 12 months of age, suggesting that current guidelines
are safe, despite the current low rate of compliance.
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